Vertex Pharmaceuticals Inc (NASDAQ:VRTX) - Share price


Stock Report

Vertex Pharmaceuticals Inc VRTX

Last Price
$187.09

Day Change
2.15|1.16%

As of 19/08/2019
18:08:30 EDT | USD
Minimum 15 Minutes Delay.

Last Close184.94
Day Range185.88 - 187.71
Mkt Cap48.09Bil
52-Wk Range151.80 - 195.81
Yield %-
ISINUS92532F1003
Volume963,229
P/E21.91
P/S14.08
P/CF32.76

Share Price

Financials
201620172018
More ...
Income Statement
Revenue1,702.182,488.653,047.60
Operating Income11.20392.83663.97
Net Income-112.05263.482,096.90
Basic EPS-0.461.068.24
Avg. Diluted Shares Outstanding245253259
Balance Sheet
Current Assets1,831.542,648.963,843.11
Non Current Assets1,065.25897.052,402.79
Total Assets2,896.793,546.016,245.90
Current Liabilities792.54807.261,120.29
Total Liabilities1,558.601,503.711,810.70
Total Equity1,156.582,028.584,435.20
Cash Flow
Operating Cash Flow236.10844.941,270.29
Capital Expenditure-56.56-259.42-95.52
Free Cash Flow179.54585.521,174.76

In millions, except "Basic EPS". Currency is USD.

Company Profile

Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Its products include SYMDEKO, ORKAMBI, and KALYDECO.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

2,500
Key Stats
More ...
Price/Earning TTM21.31
Price/Book9.38
Price/Sales TTM13.92
Rev Growth (3 year avg)43.45
EPS Growth (3 year avg)-
Operating Margin % TTM21.79
Net Margin % TTM68.80
ROE TTM64.87
Debt/Equity0.13
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.